In intestinal lesions of IBD patients, we confirmed that there is a subset shift with a lower proportion of NKp44+ ILC3, on the one hand and more ILC1 and more NCR− (NKp44−) ILC3, on the other hand (14, 27). The gene discussed is NCR2; the disease is inflammatory bowel disease.